Effects of Omega 3 in Hemodialysis Patients

The aim of the study was to determine the effects of a 3-week fish oil oral supplementation on the metabolic fate and thermogenic effect of an oral glucose load in hemodialysis patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hemodialysis Chronic Disease Disease Attributes End Stage Renal Disease Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Glucose Metabolism Disorders Hyperinsulinism Insulin Resistance Kidney Diseases Kidney Failure, Chronic Male Urogenital Diseases Metabolic Diseases Nutritional and Metabolic Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Renal Insufficiency Renal Insufficiency, Chronic Urogenital Diseases Urologic Diseases

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Laboratoire Régional de Nutrition Humaine

Brest, F-29200, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

hemodialysis at least 6 months duration end stage renal disease

Exclusion criteria

- Age < 18 y ou > 75 y
Hemodialysis < 6 months
Diabetes, obesity
allergy to fish
Asthma
glucocorticoïds, propranolol,, Immunosuppressive drugs, Insulin, Somatostatin
erythropoïetin < 3 months
Cancer
Hemoglobin < 11 g/l
disease < 1 month
pregnancy
respiratory insufficiency
intensive sport practice
refusal

Treatment and study plan

fish oil supplementation

Behavioral

Primary outcomes

plasma glucose utilization
glucose-induced thermogenesis

Sponsors and collaborators

Lead sponsor

Laboratoire Régional de Nutrition Humaine

Other

Registry information

Official study title

Effets of Fish Oil on Metabolic Fate of an Oral Glucose Load in Patients With End Stage Renal Disease Undergoing Hemodialysis

Important dates

Study start: 2003
Study completion: 2003
First posted: Feb 6, 2007
Registry last updated: Mar 3, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed